Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-005618

CVP, Chief Financial Officer gave up 4,678 shares (to pay taxes)

  • CVP, Chief Financial Officer acquired 6,062 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-07 Exercise or conversion : show line 1 in the form +6,062 22,972 D
2023-05-07 Shares withheld for taxes : show line 2 in the form −3,004 $88.74 $266,575 19,968 D
2023-05-08 Shares withheld for taxes : show line 3 in the form −1,674 $88.74 $148,551 18,294 D

Table II: Derivative

1 line
Date Transaction Shares Expires Underlying Owned after D/I
2023-05-07 Exercise or conversion : show line 4 in the form Performance Rights −6,062 2027-05-06 6,062 1,663 D
Loading xslF345X04/doc4.xml…